Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert-Jan Creemers

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 18, 2016
Developing a core set of patient-reported outcomes in pancreatic cancer: A Delphi surveyArja Gerritsen, Marc Jacobs, Inge Henselmans, et al.
Cancer|March 31, 2007
The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 yearsMarloes van der Leest, Lisette Evers, Maurice J C van der Sangen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2009
Patterns of local recurrence in locally advanced rectal cancer after intra-operative radiotherapy containing multimodality treatmentMiranda Kusters, Fabian A Holman, Hendrik Martijn, et al.
Translational Oncology|August 16, 2024
Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker studyCharlotte I Stroes, Sybren L Meijer, Geert-Jan Creemers, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 14, 2020
Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort studyWillemieke P M Dijksterhuis, Rob H A Verhoeven, Sybren L Meijer, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 17, 2019
Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patientsSophie Kurk, Petra Peeters, Rebecca Stellato, et al.
International Journal of Cancer|June 19, 2025
Real-world study on fluoropyrimidine-related toxicity outcomes in cancer patients with select DPYD variant alleles that received DPYD genotype-guided dosingSofía L J Peeters, Didier Meulendijks, Zerina Kadric, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2020
Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: A population-based studyWillemieke P M Dijksterhuis, Rob H A Verhoeven, Marieke Pape, et al.
BJS Open|May 13, 2022
MRI tumour regression grade in locally recurrent rectal cancerEva L K Voogt, Stefi Nordkamp, Desley M G I van Zoggel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 27, 2021
First- and Second-Line Palliative Systemic Treatment Outcomes in a Real-World Metastatic Pancreatic Cancer CohortEsther N Pijnappel, Willemieke P M Dijksterhuis, Lydia G van der Geest, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|February 18, 2016
Developing a core set of patient-reported outcomes in pancreatic cancer: A Delphi surveyArja Gerritsen, Marc Jacobs, Inge Henselmans, et al.
Cancer|March 31, 2007
The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 yearsMarloes van der Leest, Lisette Evers, Maurice J C van der Sangen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2009
Patterns of local recurrence in locally advanced rectal cancer after intra-operative radiotherapy containing multimodality treatmentMiranda Kusters, Fabian A Holman, Hendrik Martijn, et al.
Translational Oncology|August 16, 2024
Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker studyCharlotte I Stroes, Sybren L Meijer, Geert-Jan Creemers, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 14, 2020
Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort studyWillemieke P M Dijksterhuis, Rob H A Verhoeven, Sybren L Meijer, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 17, 2019
Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patientsSophie Kurk, Petra Peeters, Rebecca Stellato, et al.
International Journal of Cancer|June 19, 2025
Real-world study on fluoropyrimidine-related toxicity outcomes in cancer patients with select DPYD variant alleles that received DPYD genotype-guided dosingSofía L J Peeters, Didier Meulendijks, Zerina Kadric, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2020
Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: A population-based studyWillemieke P M Dijksterhuis, Rob H A Verhoeven, Marieke Pape, et al.
BJS Open|May 13, 2022
MRI tumour regression grade in locally recurrent rectal cancerEva L K Voogt, Stefi Nordkamp, Desley M G I van Zoggel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 27, 2021
First- and Second-Line Palliative Systemic Treatment Outcomes in a Real-World Metastatic Pancreatic Cancer CohortEsther N Pijnappel, Willemieke P M Dijksterhuis, Lydia G van der Geest, et al.
Pageof 10